Cost-effective cervical cancer prevention possible in Brazil

September 2007
PharmacoEconomics & Outcomes News;9/8/2007, Issue 536, p4
The article discusses research being done on the development of a cost effective strategy for cervical cancer prevention in Brazil. It references a study by S. J. Goldie et al. published in the August 2007 issue of the "Vaccine." The researchers concluded that a human papillomavirus (HPV) vaccination program would be a cost effective strategy for preventing cervical cancer in Brazil. The researchers utilized an empirically calibrated simulation model of cervical carcinogenesis to evaluate HPV 16 and 18 vaccination of adolescent females.


Related Articles

  • Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy. Brotherton, Julia M. L.; Kaldor, John M.; Garland, Suzanne M. // Sexual Health (14485028);Sep2010, Vol. 7 Issue 3, p310 

    The article provides information on a study which proposed a possible multifaceted strategy to human papillomavirus (HPV) related surveillance in Australia following the adoption of a national HPV vaccination program. Main components discussed in detail are monitoring of vaccine coverage,...

  • Vaccine proven to prevent cervical cancer.  // GP: General Practitioner;5/11/2007, p2 

    The article offers information regarding a study on the HPV vaccine Gardasil undertaken by the researchers of the U.S. The results of the study of Gardasil have revealed that it is nearly 100 per cent effective against the two types of HPV responsible for most cases of cervical cancer. The study...

  • Immunogenicity and Reactogenicity of a Novel Vaccine for Human Papillomavirus 16: A 2-Year Randomized Controlled Clinical Trial. Poland, Gregory A.; Jacobson, Robert M.; Koutsky, Laura A.; Tamms, Gretchen M.; Railkar, Radha; Smith, Judith F.; Bryan, Janine T.; Cavanaugh, Paul F.; Jansen, Kathrin U.; Barr, Eliav // Mayo Clinic Proceedings;May2005, Vol. 80 Issue 5, p601 

    OBJECTIVE: To evaluate the immunogenicity, reactogenicity, and tolerability of a prototype human papillomavirus (HPV) 16 virusilke particle (VLP) vaccine directed against the L1 capsid protein. SUBJECTS AND METHODS: We enrolled healthy nonpregnant women aged 18 to 26 years into a 2-year,...

  • The Relationship between Oral Squamous Cell Carcinoma and Human Papillomavirus: A Meta-Analysis of a Chinese Population (1994-2011). Changtai Zhu; Yang Ling; Chunlei Dong; Xifa Zhou; Feng Wang // PLoS ONE;May2012, Vol. 7 Issue 5, p1 

    Background: Previous studies indicated that oral squamous cell carcinomas (OSCC) might be related to human papilloma virus (HPV) infection. However, up to now, there still lacks a large sample study to analyze the relationship between OSCC in a Chinese population and oral HPV infection. In the...

  • Chinese medical students' knowledge, attitude and practice towards human papillomavirus vaccination and their intention to recommend the vaccine. Liu, Anthony; Ho, Frederick K.; Chan, Lily K. L.; Ng, Joanne Y. W.; Li, Sophia L.; Chan, Godfrey C. F.; Leung, Ting Fan; Ip, Patrick; Chan, Lily Kl; Ng, Joanne Yw; Chan, Godfrey Cf // Journal of Paediatrics & Child Health;Mar2018, Vol. 54 Issue 3, p302 

    Aim: The human papillomavirus (HPV) vaccine is effective in preventing cervical cancer, but its global uptake rate in vulnerable populations is unsatisfactory. Physician's recommendation is an important determinant for vaccine uptake, but we have limited understanding on the...

  • Epidemiology of cervical cancer in Latin America. Capote Negrin, Luis G. // Ecancermedicalscience;2015, Vol. 9 Issue 577-607, p1 

    The basic aspects of the descriptive epidemiology of cervical cancer in Latin America are presented. A decrease in the incidence and mortality rates has been observed in the period from 2000 to 2012 in all countries across the region, this has not occurred at the same proportions, and in many...

  • Formative research to shape HPV vaccine introduction strategies in Peru. Bartolini, Rosario M.; Drake, Jennifer Kidwell; Creed-Kanashiro, Hilary M.; Díaz-Otoya, Margarita M.; Mosqueira-Lovón, Nelly Rocío; Penny, Mary E.; Winkler, Jennifer L.; LaMontagne, Scott; Bingham, Allison // Salud Pública de México;may2010, Vol. 52 Issue 3, p226 

    Objetivo. Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones políticas vinculadas al cáncer cervical y a la vacuna contra el VPH para diseñar una estrategia apropiada de introducción de la vacuna contra el VPH. Material y métodos....

  • Aspects of Prophylactic Vaccination against Cervical Cancer and Other Human Papillomavirus-Related Cancers in Developing Countries. Natunen, Kari; Lehtinen, Johannes; Namujju, Proscovia; Sellors, John; Lehtinen, Matti // Infectious Diseases in Obstetrics & Gynecology;2011, Vol. 2011, Special section p1 

    Cervical cancer and other human papillomavirus- (HPV-) related cancers are preventable, but preventive measures implemented in developing countries and especially in low-income rural regions have not been effective. Cervical cancer burden derived from sexually transmitted HPV infections is the...

  • Identification of human papillomaviruses from formalin-fixed, paraffin-embedded pre-cancer and invasive cervical cancer specimens in Zambia: a cross-sectional study. Bateman, Allen C.; Katundu, Katundu; Polepole, Pascal; Shibemba, Aaron; Mwanahamuntu, Mulindi; Dittmer, Dirk P.; Parham, Groesbeck P.; Chibwesha, Carla J. // Virology Journal;2015, Vol. 12 Issue 1, p81 

    Background The most common human papillomavirus (HPV) genotypes isolated from cervical cancer in select African countries are HPV-16, HPV-18, HPV-35, and HPV-45, but the most common genotypes in Zambia are unknown. The overall objective of this study was to assess the potential impact of current...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics